Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand

NCT04266392 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT04266392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04266392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand
Lead sponsor
Stony Brook University
Phase
Phase 1
Overall status
Completed
Start date
December 16, 2019
Completion date
October 15, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer